Description: GPR35 agonist; more potent than zaprinast (Cat. No. 0947)
Chemical Name: 4-[[2-[(2-Fluorophenyl)amino]-4-oxo-5(4H)-thiazolylidene]methyl]benzoic acid
Purity: ≥98% (HPLC)
Biological Activity
Technical Data
Solubility
Calculators
Datasheets
References
Biological Activity
GPR35 agonist (pEC50 values are 7.59 and 8.36 for β-arrestin and Gαq-i5 Ca2+ assays respectively). Displays 1000-fold greater potency at human GPR35 receptors relative to mouse and rat GPR35 orthologs in an IP1 accumulation assay. More potent than zaprinast (Cat. No. 0947).
Technical Data
M. Wt
342.34
Formula
C17H11FN2O3S
Storage
Store at +4°C
Purity
≥98% (HPLC)
CAS Number
494191-73-0
PubChem ID
5766343
InChI Key
SYCKPHBALHXMIR-ZROIWOOFSA-N
Smiles
O=C1N=C(NC3=CC=CC=C3F)S/C1=CC2=CC=C(C(O)=O)C=C2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
Solvent
Max Conc. mg/mL
Max Conc. mM
Solubility
DMSO
3.42
10
Preparing Stock Solutions
The following data is based on the product molecular weight 342.34. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass
1 mg
5 mg
10 mg
1 mM
2.92 mL
14.61 mL
29.21 mL
5 mM
0.58 mL
2.92 mL
5.84 mL
10 mM
0.29 mL
1.46 mL
2.92 mL
50 mM
0.06 mL
0.29 mL
0.58 mL
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets
Certificate of Analysis / Product Datasheet
Safety Datasheet
Select another language:
View SDS
References
References are publications that support the products' biological activity.
Neetoo-Isseljeeet al (2013) High-throughput identification and characterization of novel, species-selective GPR35 agonists. J.Pharmacol.Exp.Ther. 344 568 PMID: 23262279